Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25382
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoraliyage, Harsha-
dc.contributor.authorSilva, Daswin De-
dc.contributor.authorRanasinghe, Weranja-
dc.contributor.authorAdikari, Achini-
dc.contributor.authorAlahakoon, Damminda-
dc.contributor.authorPrasad, Raj-
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.authorBolton, Damien M-
dc.date2020-
dc.date.accessioned2020-11-25T04:54:38Z-
dc.date.available2020-11-25T04:54:38Z-
dc.date.issued2020-11-18-
dc.identifier.citationThe Oncologist 2020; online first: 18 Novemberen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25382-
dc.description.abstractThe lockdown measures of the ongoing COVID-19 pandemic have disengaged patients with cancer from formal health care settings, leading to an increased use of social media platforms to address unmet needs and expectations. Although remote health technologies have addressed some of the medical needs, the emotional and mental well-being of these patients remain underexplored and underreported. We used a validated artificial intelligence framework to conduct a comprehensive real-time analysis of two data sets of 2,469,822 tweets and 21,800 discussions by patients with cancer during this pandemic. Lung and breast cancer are most prominently discussed, and the most concerns were expressed regarding delayed diagnosis, cancellations, missed treatments, and weakened immunity. All patients expressed significant negative sentiment, with fear being the predominant emotion. Even as some lockdown measures ease, it is crucial that patients with cancer are engaged using social media platforms for real-time identification of issues and the provision of informational and emotional support.en
dc.language.isoeng-
dc.subjectCOVID-19en
dc.titleCancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Oncologisten
dc.identifier.affiliationMD Anderson Cancer Center, University of Texas, Houston, Texas, USAen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationEJ Whitten Prostate Cancer Research Centre at Epworth Healthcare, Melbourne, Australiaen
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationResearch Centre for Data Analytics and Cognition, La Trobe University, Melbourne, Australiaen
dc.identifier.affiliationNational Health Service Trust, North Bristol, England, United Kingdom..en
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.doi10.1002/onco.13604en
dc.type.contentTexten
dc.identifier.orcid0000-0002-6212-8312en
dc.identifier.pubmedid33210442-
local.name.researcherBolton, Damien M
item.languageiso639-1en-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.grantfulltextopen-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptUrology-
Appears in Collections:Journal articles
Files in This Item:
File Description SizeFormat 
25382.pdf665.55 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

74
checked on Nov 16, 2024

Download(s)

94
checked on Nov 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.